Bionano Genomics (BNGO)
Optical genome mapping systems, software and consumables for structural-variation analysis.
Something off on this page? Send us feedback.
Sells optical genome mapping systems, recurring chips and reagents, analysis software, sample-purification tools and limited laboratory services. The model increasingly depends on utilization of an installed base by research and clinical laboratories, while instrument products are designated for research use only.
Combines optical genome mapping systems—Saphyr and Stratys—with single-use chips, sample-preparation kits and reagents. Labeled, ultra-high-molecular-weight DNA is linearized in nanochannels and imaged to identify large structural variation, a complement to base-by-base sequencing.
Extends the workflow with VIA, Bionano Access, Nexus Copy Number and Compute On Demand for analysis, interpretation and reporting across OGM, sequencing and microarray data. The Ionic system isolates and purifies nucleic acids for OGM and other uses; a San Diego laboratory provides limited OGM testing and data services.
Serves research institutions, clinical laboratories and life-science companies across international markets. Instruments are research-use-only; commercial progress depends on laboratory adoption and use of the installed base, manufacturing partners, evidence, reimbursement pathways for laboratory services and continued regulatory compliance.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| May 20, 2025 | Maxim Group | Upgrade | Target: — | Target: $8 |
| Nov 15, 2024 | Ladenburg Thalmann | Downgrade |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $9.9M · Total debt $6.7M · Total assets $47.6M · Shareholders' equity $31.6M
- Revenue
- $8.2M
- Operating income
- −$7.2M
- Net income
- −$7.4M
No dividends on record.
| Institutions | 6.02% | 709.4K shares | |
|---|---|---|---|
| 33 holders · as of Jun 30, 2026 | |||
| Insiders | 0.10% | 11.7K shares | |
| 7 holders · as of Sep 9, 2026 | |||
| Strategic holders | 14.08% | 1.66M shares | |
| 3 holders · as of Feb 17, 2026 | |||
| Other | 79.80% | 9.40M shares | |
| remainder | |||
11.78M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
CVI Investments, Inc.Strategic | 9.59% | 1.13M | filed Feb 17, 2026 |
Lind Global Fund III LPInstitution | 8.92% | 1.05M | filed Feb 17, 2026 |
Lincoln Alternative Strategies LLCStrategic | 4.46% | 525,000 | filed Sep 17, 2025 |
Gsa Capital Partners LLPInstitution | 1.28% | 150,284 | as of Jun 30, 2026 |
Carret Asset Management, LLCInstitution | 1.06% | 125,000 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 4, 2026 | Albert Luderer | director, officer: Interim Chief Executive | +4,000 | $1.21 |
| Aug 21, 2026 | Albert Luderer | director, officer: Interim Chief Executive | +4,000 | $1.22 |
